Tag: clinical trials

Case Studies: Surveillance-Driven Interventions That Protected Patients

Posted on By digi

Case Studies: Surveillance-Driven Interventions That Protected Patients Case Studies: Surveillance-Driven Interventions That Protected Patients The landscape of clinical trials is continually evolving, particularly with the rise of surveillance-driven interventions that are crucial for protecting patient safety and data integrity. This guide provides a comprehensive overview of the effective implementation of these interventions in the context…

Read More “Case Studies: Surveillance-Driven Interventions That Protected Patients” »

Statistical Data Surveillance

Tools and Platforms for Automated Statistical Data Surveillance

Posted on By digi

Tools and Platforms for Automated Statistical Data Surveillance Tools and Platforms for Automated Statistical Data Surveillance The landscape of clinical trials is evolving, particularly in the realm of statistical data surveillance. In recent years, technologies and methodologies have emerged to allow for effective remote monitoring and oversight of clinical trials, including those focusing on ankylosing…

Read More “Tools and Platforms for Automated Statistical Data Surveillance” »

Statistical Data Surveillance

Training Clinical and Data Teams on CDISC Concepts and Value

Posted on By digi

Training Clinical and Data Teams on CDISC Concepts and Value In the ever-evolving landscape of clinical research, understanding the principles and applications of the Clinical Data Interchange Standards Consortium (CDISC) is paramount for professionals involved in ankylosing spondylitis clinical trials. This article aims to provide a comprehensive step-by-step guide for training clinical and data teams…

Read More “Training Clinical and Data Teams on CDISC Concepts and Value” »

Data Standards (CDISC: SDTM, ADaM)

Integrating Data Standards Into Protocol, SAP and CRF Design

Posted on By digi

Integrating Data Standards Into Protocol, SAP and CRF Design Integrating Data Standards Into Protocol, SAP and CRF Design In the ever-evolving landscape of clinical research, ensuring data integrity and standardization is paramount. This article delves into the integration of data standards, specifically focusing on the Clinical Data Interchange Standards Consortium (CDISC) and its vital components…

Read More “Integrating Data Standards Into Protocol, SAP and CRF Design” »

Data Standards (CDISC: SDTM, ADaM)

Group-Sequential Designs: Statistical Concepts and Practical Execution

Posted on By digi

Group-Sequential Designs: Statistical Concepts and Practical Execution Group-Sequential Designs: Statistical Concepts and Practical Execution In the landscape of clinical trials, the need for efficiency and ethical considerations is paramount. Group-sequential designs provide robust statistical methodologies that allow researchers to conduct interim analyses, ensuring that clinical trials can be adapted based on accumulating data. This article…

Read More “Group-Sequential Designs: Statistical Concepts and Practical Execution” »

Interim Analyses & Alpha Spending

Surveillance in DCT and eSource-Heavy Trials With High-Volume Data

Posted on By digi

Surveillance in DCT and eSource-Heavy Trials With High-Volume Data Surveillance in DCT and eSource-Heavy Trials With High-Volume Data The integration of Digital Clinical Trials (DCT) and eSource methodologies has transformed the landscape of clinical research, particularly for trials involving high-volume data. This article serves as a comprehensive tutorial aimed at clinical operations, regulatory affairs, and…

Read More “Surveillance in DCT and eSource-Heavy Trials With High-Volume Data” »

Statistical Data Surveillance

Documenting Statistical Surveillance Methods in Protocol and SAP

Posted on By digi

Documenting Statistical Surveillance Methods in Protocol and SAP Documenting Statistical Surveillance Methods in Protocol and SAP Statistical surveillance is a critical component in ensuring the integrity and validity of clinical trial data, particularly in the conduct of sma clinical trials. Proper documentation of statistical surveillance methods in both the Trial Protocol and Statistical Analysis Plan…

Read More “Documenting Statistical Surveillance Methods in Protocol and SAP” »

Statistical Data Surveillance

Tools and Automation for SDTM/ADaM Mapping and Validation

Posted on By digi

Tools and Automation for SDTM/ADaM Mapping and Validation In the realm of clinical trials, the importance of adhering to standardized data formats cannot be overstated. Standardized formats such as CDISC’s Study Data Tabulation Model (SDTM) and Analysis Data Model (ADaM) facilitate consistent data collection, management, and analysis across clinical research projects. This article provides a…

Read More “Tools and Automation for SDTM/ADaM Mapping and Validation” »

Data Standards (CDISC: SDTM, ADaM)

Case Studies: Standards-Driven Programs That Reduced Cycle Times

Posted on By digi

Case Studies: Standards-Driven Programs That Reduced Cycle Times In the realm of clinical trials, the emphasis on efficiency and accuracy has never been more paramount. With increasing pressure on clinical operations professionals to deliver quality data at faster rates, understanding how standards-driven programs can enhance trial efficiency is crucial. This comprehensive guide focuses on key…

Read More “Case Studies: Standards-Driven Programs That Reduced Cycle Times” »

Data Standards (CDISC: SDTM, ADaM)

Maintaining Trial Integrity and Confidentiality During Interim Looks

Posted on By digi

Maintaining Trial Integrity and Confidentiality During Interim Looks Maintaining Trial Integrity and Confidentiality During Interim Looks Interim analyses play a critical role in the management and oversight of clinical trials. Ensuring the integrity and confidentiality of these analyses is imperative for the credibility of clinical research outcomes. With the increasing complexity of clinical trials, especially…

Read More “Maintaining Trial Integrity and Confidentiality During Interim Looks” »

Interim Analyses & Alpha Spending